Literature DB >> 24488284

Screening programme for retinopathy of prematurity in Ilorin, Nigeria: a pilot study.

D Ademola-Popoola1, O Adesiyun, I A Durotoye, T O Obasa.   

Abstract

BACKGROUND: The Neonatal Intensive Care Unit (NICU) of our hospital has a 30% survival rate among babies born premature weighing <1,000g. This hospital serves about 10 million people; there was no retinopathy of prematurity (ROP) screening program in place in Nigeria.
MATERIALS AND METHODS: Babies born premature were recruited based on preset criteria: ≤ 35 weeks Gestation Age and birth weight ≤ 1.9 kg. The first retina examination was done at 3-4 weeks post-delivery and were documented on a proforma and analyzed with SPSS 15 Statistical Package.
RESULTS: 58 eyes of 29 babies were examined. The birth weight range was 950-1900g, 17(58.6%) babies were ≤ 1500g, and 12 (41.4%) 1500-1900g. The Gestation age range was 27-35 weeks with a mean of 30. Avascularity in retina zones 2&amp;3 was found in 52(89.6%) eyes mostly among babies <32 weeks gestation age and <1500g. Risk factors associated with retinal avascularity are highlighted. The challenges were with co-ordination of follow-up visits and accessibility to treatment such as laser and newer treatment methods.
CONCLUSION: A cost effect screening criteria for ROP in Nigeria is suggested to include birth weight ≤ 1500g and gestational age ≤ 32 weeks. Dedicated staff &amp; resources for treatment and imaging are needed for a successful program. An opportunity exists to study the effect of genetics on the development and severity of ROP among native African babies.

Entities:  

Mesh:

Year:  2013        PMID: 24488284

Source DB:  PubMed          Journal:  West Afr J Med        ISSN: 0189-160X


  4 in total

1.  Retinopathy of prematurity in Africa: a systematic review.

Authors:  Daniel Wang; Roseline Duke; Rv Paul Chan; J Peter Campbell
Journal:  Ophthalmic Epidemiol       Date:  2019-03-01       Impact factor: 1.648

2.  Strengthening retinopathy of prematurity screening and treatment services in Nigeria: a case study of activities, challenges and outcomes 2017-2020.

Authors:  Dupe S Ademola-Popoola; Iretiola B Fajolu; Clare Gilbert; Bolutife A Olusanya; Oluwatoyin H Onakpoya; Chinyelu N Ezisi; Kareem O Musa; Robison Vernon Paul Chan; Valentina W Okeigbemen; Rilwan C Muhammad; Aeesha N J Malik; Adedayo O Adio; Olubunmi T Bodunde; Abdulkadir L Rafindadi; Tunji S Oluleye; Olukemi O Tongo; Sarat A Badmus; Olufunmilayo V Adebara; Tapas Ranjan Padhi; Beatrice N Ezenwa; Tokunbo S Obajolowo; Lateefat B Olokoba; Victoria A Olatunji; Yewande Olubunmi Babalola; Mary O Ugalahi; Adetunji Adenekan; Omotayo O Adesiyun; Jagdish Sahoo; Marilyn T Miller; Odarosa M Uhumwangho; Adeduntan S Olagbenro; Ebunoluwa A Adejuyigbe; Chinyere V C Ezeaka; Olugbenga Mokuolu; Tinuade A Ogunlesi; Olusoga B Ogunfowora; Isa Abdulkadir; Fatima L Abdullahi; Abosede T Fabiyi; Laila H L Hassan; Aderonke M Baiyeroju; Peace I Opara; Kehinde Oladigbolu; Augusta U Eneh; Bassey E Fiebai; Fatima A Mahmud-Ajeigbe; Elijah N Peter; Hawwa S Abdullahi
Journal:  BMJ Open Ophthalmol       Date:  2021-08-23

3.  Nigerian neonatologists perception and experience with retinopathy of prematurity.

Authors:  Adedayo Adio; Sadiat Saka-Eletu Aliyu; Aliyu Hamza Balarabe; Kehinde Mosudi; Dupe Ademola-Popoola; Teslim Lawal
Journal:  J Public Health Afr       Date:  2021-06-23

4.  Incidence and risk factors of retinopathy of prematurity in Korle-Bu Teaching Hospital: a baseline prospective study.

Authors:  Imoro Zeba Braimah; Christabel Enweronu-Laryea; Adziri Harold Sackey; Ernest Kenu; Kofi Agyabeng; Imelda-Odille Dziffa-Bella Ofori-Adjei; Vera Beyuo; Aaron Oku; Vera Adobea Essuman
Journal:  BMJ Open       Date:  2020-08-05       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.